1Buysschaert I, Schmidt T, Roncal C, et al. Genetics, epigenetics and pharmaco-( epi ) genomies in angiogenesis [ J ]. J Cell Mol Med, 2008,12(6B) :2533 -2551.
2MeQuown SC, Wood MA. Epigenetic regulation in substance use disorders [ J]. Curr Psychiatry Rep ,2010,12 (2) : 145-153.
3Rodolphe Taby, Jean-Pierre J. Issa cancer epigenetics [ J ]. CA Cancer J Clin, 2010,60:376-392.
4Humeniuk R, Mishra PJ, Beino JR, et al. Molecular targets for epigenetic therapy of cancer [ J ]. Curt Pharm Biotechnol, 2009, 10 (2) :161-165.
5Glass JL, Thompson RF, Khulan B, et al. CG dinucleotide clustering is a species specific property of the genome[ J]. Nucleic Acids Res, 2007,35:6798 -6807.
6EllisL, Atadja PW, JohnstoneRW. Epigenetics in cancer: targeting chromatin modifications [J]. Mol Cancer Ther,2009, 6(8): 1409-1420.
7Illingworth RS, Bird AP. CpG islands a rough guide [ J]. FEBS Lett, 2009, 583(11) : 1713 -1720.
8Bodo B, Fank L..DNA methyltransferase inhibitors. Old and new drugs from an epigenetic cancer therapy [ J]. Trends Pharmacol Sci,2004,25 ( 11 ) : 551-554.
9Costello JF, Plass C, Methylationmatters [ J]. J Med Genet, 2001, 38(5) : 285 -303.
10Tse KY, Liu VW, Chan DW, el al. Epigenetic aheration ot the metallothionein 1 E gene in human endometrial carcinomas [ J ]. Tumour Biol,2009,30:93-99.
3Ohta M, Inoue H, Coticelli MG, et al.The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers[J]. Cell, 1996,84(4): 587-598.
4Kawaguchi K, Yashima K, Koda M,et al.Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype[J]. Br J Cancer,2004,90(3):672-677.
5Huiping C, Kristjansdottir S, Bergthorsson JT,et al. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer[J]. Eur J Cancer,2002,38(5):728-735.
6Lee SH, Kim CJ, Park HK,et al. Characterization of aberrant FHIT transcripts in gastric adenocarcinomas[J]. Exp Mol Med,2001,33(3):124-130.
7Herman JG,Jeremy RG,Sanna M,et al.Methylation-specific PCR:a novel PCR assay for methylation status for CpG islands[J].Proc Natl Sci USA,1996,93(18):9821-9826.
8Zochbauer-Müller S, Kwun M. Fong, Anirban Maitra, et al.5′-CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer[J]. Cancer Res,2001,61(9):3581-3585.
9Yang QF, Nakamura M, Nakamura Y,et al. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer[J]. Clin Cancer Res,2002, 8(9):2890-2893.
10Zheng S,Ma X,Zhang L,et al.Hypermethylation of the5'CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia[J].Cancer Res,2004,64(6):2000-2006.
